4-(5-((2-chlorophenyl)amino)-1H-pyrazolo[3,4-c]pyridin-1-yl)-N-(oxetan-3-yl)thiophene-2-carboxamide

ID: ALA4872832

PubChem CID: 156155321

Max Phase: Preclinical

Molecular Formula: C20H16ClN5O2S

Molecular Weight: 425.90

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(NC1COC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)ncc32)cs1

Standard InChI:  InChI=1S/C20H16ClN5O2S/c21-15-3-1-2-4-16(15)25-19-5-12-7-23-26(17(12)8-22-19)14-6-18(29-11-14)20(27)24-13-9-28-10-13/h1-8,11,13H,9-10H2,(H,22,25)(H,24,27)

Standard InChI Key:  XXPJQSSWRLLVEZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    2.9551  -13.5373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6628  -13.1287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2474  -13.1287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9551  -14.3545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2474  -12.3115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8269  -11.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2491  -11.1512    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6712  -11.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4115  -13.4621    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.9583  -12.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5497  -12.1470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7504  -12.3170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8820  -11.4004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0168  -10.0896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4702  -10.6970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7603  -10.4209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6763  -11.2364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3397  -11.7150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0874  -11.3793    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1677  -10.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5034  -10.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9118  -10.2224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5764  -10.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4940  -11.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1578  -11.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9029  -11.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9802  -10.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3155  -10.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7493  -11.8483    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  5  1  0
  2  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  2  2  0
 11 13  1  0
 13 17  1  0
 16 14  1  0
 14 15  2  0
 15 13  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 24 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872832

    ---

Associated Targets(Human)

MAPK10 Tchem c-Jun N-terminal kinase 3 (3396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK9 Tchem c-Jun N-terminal kinase 2 (4655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.90Molecular Weight (Monoisotopic): 425.0713AlogP: 4.01#Rotatable Bonds: 5
Polar Surface Area: 81.07Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.99CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.65

References

1. Feng Y, Park H, Ryu JC, Yoon SO..  (2021)  N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors.,  12  (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334]

Source